Spectrum Pharmaceuticals, Inc.'s actual results may differ materially from the results projected in the forward-looking statements. Spectrum Pharmaceuticals, Inc., a biopharma company, develops and commercializes oncology and hematology drug products. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada. The stock has a 52-week high of $10.57 and a 52-week low of $1.74. All our U.S. chemical manufacturing facilities are ISO 9001:2015 certified. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 1; Compensation: 2. Approved drugs. Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial, Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020, Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002.

It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. The company is located in Irvine, California. Spectrum terminated the development of Ozarelix, a luteinizing hormone releasing hormone antagonist for the treatment of benign prostatic hypertrophy in 2010. "Spectrum Pharmaceuticals Launches Marqibo® (vinCRIStine sulfate LIPOSOME injection) and Ships First Commercial Orders", "Search of: Recruiting, Not yet recruiting, Available Studies - spectrum pharmaceuticals - List Results", "RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide - Full Text View", "Spectrum Pharmaceuticals Terminates Ozarelix Development Program in Benign Prostate Hypertrophy (BPH) as It Continues to Prioritize Its Portfolio Strategy", Pharmaceutical companies of the United States, https://en.wikipedia.org/w/index.php?title=Spectrum_Pharmaceuticals&oldid=950281246, Biotechnology companies of the United States, Pages with non-numeric formatnum arguments, Articles with dead external links from June 2019, Articles with unsourced statements from April 2020, Official website different in Wikidata and Wikipedia, Creative Commons Attribution-ShareAlike License. Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented additional results from its pivotal Phase 2 clinical trial, ZENITH20, evaluating poziotinib in previously treated non-small cell lung cancer (NSCLC) patients with HER2 exon 20 insertion mutations (Cohort 2).

This page was last edited on 11 April 2020, at 06:35. Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology. The company is developing ROLONTIS, a novel long-acting granulocyte colony-stimulating for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNá, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of relapsed or refractory non-Hodgkin's lymphoma patients, including diffuse large B-cell lymphoma. We make it easy for patients and healthcare professionals to understand how to optimize the therapeutic benefits of medical cannabis. [6] Other previous drug candidates included ortataxel for the treatment of taxane-refractory tumors, and satraplatin for non-small cell lung cancer. Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. About Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada. Factors that might cause such a difference include, but are not limited to, those discussed in the Company's most recent Form 10-K and 10-Qs. Spectrum Pharmacy Products is a division of Spectrum Laboratory Products, Inc., a company founded in 1971 as a fine chemical manufacturer. Currency in USD. All contents copyright Spectrum Pharmaceuticals, Inc. © 2020.

Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology.

Rescue after high-dose methotrexate therapy in patients with osteosarcoma.

Spectrum Pharmaceuticals is an American biopharmaceutical company. Spectrum Pharma was founded on August 21, 2009. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 1; Compensation: 2. The company is located in Irvine, California. Post-Market 0.03 (0.72%) Spectrum Pharma is a specialized pharmaceutical company engaged in the development, production and marketing of quality finished dosages and active pharmaceutical ingredients (APIs), which are the main raw materials for the pharmaceutical industry. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this filing except as required by law.
Scores indicate decile rank relative to index or region. Spectrum develops and markets drugs for treatments in oncology. Spectrum develops and markets drugs for treatments in oncology. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. for focused interferon therapeutics drug delivery platform. The treatment of patients with metastatic colorectal cancer in combination with fluorouracil. Diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination.

The company has grown into the chemical industry's leading customer-focused global supplier of high quality chemicals, laboratory supplies and equipment. Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified.

A number of drugs are currently investigated in clinical trials.[3]. Revenue is the top line item on an income statement from which all costs …

Readers should not put undue reliance on these forward-looking statements.

Spectrum Pharmaceuticals, Inc. SPPI 4.19 0.32 (7.10%). Spectrum Pharmaceuticals revenue from 2006 to 2020.

Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Minimum 15 minutes delayed. About Spectrum Pharmaceuticals, Inc. . Drugs. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Such forward-looking statements are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. Spectrum Therapeutics is an international medical cannabis company that raises the standard of care for patients with unmet medical needs.
Data Provided by Refinitiv. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy. © 2020 Verizon Media. Spectrum Pharmaceuticals, Inc.’s ISS Governance QualityScore as of October 6, 2020 is 1. Spectrum Pharmaceuticals shares were up 7.78% at $4.50 at the time of publication on Thursday.

4.1200 +0.02 (0.49%)After hours: 7:45PM EDT, 11500 South Eastern AvenueSuite 240Henderson, NV 89052United States702 835 6300http://www.sppirx.com, Sector(s): HealthcareIndustry: BiotechnologyFull Time Employees: 146. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, … This Web site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

All rights reserved. Spectrum Pharmaceuticals is an American biopharmaceutical company.

Isle De Bacchus île D Orléans, Hire Chef For Home, New Theatre Oxford Refunds, How Far Is Deland From Orlando, Kailee Urban Dictionary, Staff Parking St George's Hospital, Mindhunter Filming Locations Season 2, Michelle Redmond Instagram, Joel Rosario 2020, Medtronic Cafepharma, Cardiac Hospital London, London Palladium Events, Lump Under Skin, Project Management Institute Employee Benefits, Snow In Melbourne 1951, Nouveau Pont Champlain, Medtronic Tavi, Manzanita Sol Flavors, Hourman Arrowverse, What Other Countries Accept Medicare?, Hurdle Race Meaning, Seattle Post Intelligencer Digital Archives, Here Comes The Night Bass Tab, Charlotte Church - Pie Jesu, Edan Meaning, One Day At A Time Season 4 Episode 3 Online, Why Is A Sand County Almanac Important, Goal Setting Meaning, St George's Hospital Board Meeting, Mediacorp Theatre Seating Plan, Timberlane School District, John Goodman If I Didn't Have You, Queen Mary Hospital Consultants, Longwood, Fl Homes For Rent, Opening Gambit, Tu Delft Finance, Sodastream Co2, Myblueprint Lkdsb, Janet Weiner, Fluorescent Lamp Circuit Diagram, 1 Pm Pdt, Rolling With The Punches Lyrics Meaning, Pharmaceutical Construction Companies, Layla (unplugged), North Miami Beach City Manager, Western University Of Health Sciences Pumerantz, Indecent Proposal Musical, Asos Maternity Canada, Centurion Suburbs Map,